Expanded phenotypic spectrum of the m.8344AG 'MERRF' mutation: data from the German mitoNET registry

Autor: Aleksandra Nadaj-Pakleza, Kristl G. Claeys, Holger Prokisch, Jörg B. Schulz, Ronald R. Lautenschläger, Joachim Weis, Klaus A. Kuhn, Thomas Klopstock, Jochen Schäfer, Marcus Deschauer, Cornelia Kornblum, Judith Altmann, Robert Kopajtich, Sandra Jackson, Diana Lehmann, Ludger Schöls, Boriana Büchner, Kathrin N. Karle
Rok vydání: 2015
Předmět:
0301 basic medicine
Male
Pathology
RNA
Mitochondrial

Cohort Studies
Epilepsy
0302 clinical medicine
epidemiology [MERRF Syndrome]
Mitochondrial myopathy
Germany
Medicine
genetics [RNA]
Registries
Age of Onset
genetics [MERRF Syndrome]
Brain
Middle Aged
Heteroplasmy
Pedigree
Phenotype
Neurology
RNA
Transfer
Lys

Female
medicine.symptom
Adult
medicine.medical_specialty
Ataxia
Adolescent
Mitochondrial disease
genetics [RNA
Transfer
Lys]

epidemiology [Germany]
03 medical and health sciences
Humans
ddc:610
diagnostic imaging [Brain]
Aged
Cerebellar ataxia
business.industry
medicine.disease
MERRF Syndrome
030104 developmental biology
drug therapy [MERRF Syndrome]
physiopathology [MERRF Syndrome]
Mutation
Myoclonic epilepsy
RNA
Neurology (clinical)
business
Myoclonus
030217 neurology & neurosurgery
Zdroj: Journal of neurology 263(5), 961-972 (2016). doi:10.1007/s00415-016-8086-3
ISSN: 1432-1459
DOI: 10.1007/s00415-016-8086-3
Popis: The m.8344A>G mutation in the MTTK gene, which encodes the mitochondrial transfer RNA for lysine, is traditionally associated with myoclonic epilepsy and ragged-red fibres (MERRF), a multisystemic mitochondrial disease that is characterised by myoclonus, seizures, cerebellar ataxia, and mitochondrial myopathy with ragged-red fibres. We studied the clinical and paraclinical phenotype of 34 patients with the m.8344A>G mutation, mainly derived from the nationwide mitoREGISTER, the multicentric registry of the German network for mitochondrial disorders (mitoNET). Mean age at symptom onset was 24.5 years ±10.9 (6-48 years) with adult onset in 75 % of the patients. In our cohort, the canonical features seizures, myoclonus, cerebellar ataxia and ragged-red fibres that are traditionally associated with MERRF, occurred in only 61, 59, 70, and 63 % of the patients, respectively. In contrast, other features such as hearing impairment were even more frequently present (72 %). Other common features in our cohort were migraine (52 %), psychiatric disorders (54 %), respiratory dysfunction (45 %), gastrointestinal symptoms (38 %), dysarthria (36 %), and dysphagia (35 %). Brain MRI revealed cerebral and/or cerebellar atrophy in 43 % of our patients. There was no correlation between the heteroplasmy level in blood and age at onset or clinical phenotype. Our findings further broaden the clinical spectrum of the m.8344A>G mutation, document the large clinical variability between carriers of the same mutation, even within families and indicate an overlap of the phenotype with other mitochondrial DNA-associated syndromes.
Databáze: OpenAIRE